Illumina Challenges Ownership Rights for Patent Covering Parallele Technology Acquired by Affymetrix
An Interference is a proceeding instituted in the USPTO for determining priority of invention between two parties claiming the same invention. The party identified as the first to invent is ultimately awarded ownership and entitlement to the invention under US patent law. The invention at issue, although not currently in use at Illumina, was invented by Illumina scientists during the course of early research and development at the company. Illumina's request for interference is based on an Illumina patent application describing the invention and filed prior to the '412 Patent. The earlier filing date is expected to establish Illumina as the "senior party" in the Interference proceeding, placing on the '412 patent inventors the burden of proof to establish an earlier date of invention.
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.